Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Canada's Oldest Person is in Niagara
Man Charged with Manslaughter After Fight
EV Chargers in Port Colborne
Grant Approval for Welland Hospital
Niagara Airport Reveals Growth Plan
Police Looking for Mischief Suspects
NRP Investigating Car Fire
Federal Liberals Table Budget